EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol Reduces Systemic Immune Activation in Experimental Acute Lung Injury

Stefan Hall iD, Sufyan Faridi, Purvi Trivedi, Mathieu Castonguay, Melanie Kelly, Juan Zhou iD, Christian Lehmann

Cannabis & Cannabinoid Research · 01.10.2024 · 9 (5) · 1301-1311

DOI: 10.1089/can.2023.0039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cannabis & Cannabinoid Research, online erschienen am 07.10.2024. Verfasst von Stefan Hall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada. Hauptthemen laut MEDLINE: Cannabidiol, Acute Lung Injury, Mice, Inbred C57BL, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The underlying pathomechanism of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is the immune response to inflammation or infection within the pulmonary microcirculation. Systemic spread of pathogens, activated immune cells, and inflammatory mediators contributes significantly to mortality in patients with ARDS.

Objective

The endogenous cannabinoid system is a major modulator of the immune response during inflammation and infection. Phytocannabinoids, such as cannabidiol (CBD), have shown promising anti-inflammatory effects in several pathologies. The overall objective of this study was to evaluate the effects of CBD on local and systemic inflammation in endotoxin-induced ALI in mice. Materials and Methods: ALI was induced by pulmonary endotoxin challenge. Four groups of male C57BL/6 mice were randomized in this study: control, ALI, ALI with CBD treatment, and control with CBD treatment. Analyses of local and systemic cytokine levels, lung histology, and leukocyte activation as visualized by intravital microscopy of the intestinal and pulmonary microcirculation were performed 6 h following intranasal endotoxin administration.

Results

Pulmonary endotoxin challenge induced significant inflammation evidenced by local and systemic cytokine and chemokine release, lung histopathology, and leukocyte adhesion. Intraperitoneal CBD treatment resulted in a significant decrease in systemic inflammation as shown by reduced leukocyte adhesion in the intestinal microcirculation and reduced plasma cytokine and chemokine levels. Pulmonary chemokine levels were decreased, while pulmonary cytokine levels were unchanged. Surprisingly, the ALI score was slightly increased by CBD treatment in a manner driven by enhanced neutrophil infiltration of the alveoli.

Conclusion

In this model of experimental ALI, CBD administration was associated with reduced systemic inflammation and heterogeneous effects on pulmonary inflammation. Future studies should explore the mechanisms involved as they relate to neutrophil infiltration and proinflammatory mediator production within the lungs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolAcute Lung InjuryMice, Inbred C57BLLungCytokinesAnimalsMaleMiceLeukocytesEndotoxinsDisease Models, AnimalInflammationAnti-Inflammatory AgentsCell AdhesionMicrocirculation

Stichwörter der Autor:innen

acute lung injurycannabidiolcytokinesendocannabinoid systemmicrocirculation

Substanzen

CannabidiolCytokinesEndotoxinsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Anesthesia, Pain Management, and Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.

ORCID-Profile: Stefan Hall, Juan Zhou

Zitieren

APA

Hall, S., Faridi, S., Trivedi, P., Castonguay, M., Kelly, M., Zhou, J., & Lehmann, C. (2024). Cannabidiol Reduces Systemic Immune Activation in Experimental Acute Lung Injury. Cannabis & Cannabinoid Research, 9(5), 1301-1311. https://doi.org/10.1089/can.2023.0039

Vancouver

Hall S, Faridi S, Trivedi P, Castonguay M, Kelly M, Zhou J, et al. Cannabidiol Reduces Systemic Immune Activation in Experimental Acute Lung Injury. Cannabis & Cannabinoid Research. 2024;9(5):1301-1311. doi:10.1089/can.2023.0039

BibTeX
@article{Hall2024,
  author = {Hall, Stefan and Faridi, Sufyan and Trivedi, Purvi and Castonguay, Mathieu and Kelly, Melanie and Zhou, Juan and Lehmann, Christian},
  title = {Cannabidiol Reduces Systemic Immune Activation in Experimental Acute Lung Injury},
  journal = {Cannabis & Cannabinoid Research},
  year = {2024},
  volume = {9},
  number = {5},
  pages = {1301--1311},
  doi = {10.1089/can.2023.0039}
}
Kostenlos starten →